Mapping cardiac remodeling in chronic kidney disease
Authors:
- Nadine KaeslerNKNadine Kaesler
- Mingbo ChengMCMingbo Cheng
- James NagaiJNJames Nagai
- James O’sUllivanJOJames O’sUllivan
- Fabian PeiskerFPFabian Peisker
- Eric M. J. BindelsEBEric M. J. Bindels
- Anne BablerABAnne Babler
- Julia MoellmannJMJulia Moellmann
- Patrick DrostePDPatrick Droste
- Giulia FranciosaGFGiulia Franciosa
- Aurelien DugourdADAurelien Dugourd
- Julio Saez-RodriguezJSJulio Saez-Rodriguez
Open Access
- 24 November 2023
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 9 (47) , eadj4846
Abstract
Patients with advanced chronic kidney disease (CKD) mostly die from sudden cardiac death and recurrent heart failure. The mechanisms of cardiac remodeling are largely unclear. To dissect molecular and cellular mechanisms of cardiac remodeling in CKD in an unbiased fashion, we performed left ventricular single-nuclear RNA sequencing in two mouse models of CKD. Our data showed a hypertrophic response trajectory of cardiomyocytes with stress signaling and metabolic changes driven by soluble uremia-related factors. We mapped fibroblast to myofibroblast differentiation in this process and identified notable changes in the cardiac vasculature, suggesting inflammation and dysfunction. An integrated analysis of cardiac cellular responses to uremic toxins pointed toward endothelin-1 and methylglyoxal being involved in capillary dysfunction and TNFα driving cardiomyocyte hypertrophy in CKD, which was validated in vitro and in vivo. TNFα inhibition in vivo ameliorated the cardiac phenotype in CKD. Thus, interventional approaches directed against uremic toxins, such as TNFα, hold promise to ameliorate cardiac remodeling in CKD.Keywords
This publication has 76 references indexed in Scilit:
- The Epidermal Growth Factor Receptor and Its Ligands in Cardiovascular DiseaseInternational Journal of Molecular Sciences, 2013
- Understanding the origin, activation and regulation of matrix‐producing myofibroblasts for treatment of fibrotic diseaseThe Journal of Pathology, 2013
- RhoGEF12 controls cardiac remodeling by integrating G protein– and integrin-dependent signaling cascadesJournal of Experimental Medicine, 2013
- clusterProfiler: an R Package for Comparing Biological Themes Among Gene ClustersOMICS: A Journal of Integrative Biology, 2012
- The Homeostatic Chemokine CCL21 Predicts Mortality and May Play a Pathogenic Role in Heart FailurePLOS ONE, 2012
- CUX1: target of Akt signalling and mediator of resistance to apoptosis in pancreatic cancerGut, 2010
- Laminin deposition is dispensable for vasculogenesis but regulates blood vessel diameter independent of flowThe FASEB Journal, 2007
- Altered Expression of Disintegrin Metalloproteinases and Their Inhibitor in Human Dilated CardiomyopathyCirculation, 2006
- Decorin Is Produced by Capillary Endothelial Cells in Inflammation-Associated AngiogenesisThe American Journal of Pathology, 2001
- Atrial natriuretic polypeptide as a novel antigrowth factor of endothelial cells.Hypertension, 1992